Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit
Lung Cancer Update
00:00
Advancements in NSCLC Immunotherapy
This chapter explores the effectiveness of various immunotherapy strategies for non-small cell lung cancer (NSCLC), highlighting the role of PD-L1 status, ongoing trials, and innovative treatments like tumor treating fields. It emphasizes promising results from recent studies and the evolving landscape of immunotherapy in enhancing patient outcomes and managing resistance.
Transcript
Play full episode
